Gemina Laboratories Ltd.
GLAB.CN
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.59M
Close$
Share Statistics
| Market cap | $4.59 Million |
|---|---|
| Enterprise Value | $5.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | -0.34 |
| Outstanding Shares | 76,570,907 |
Return
| Return on Equity | 37.19% |
|---|---|
| Return on Assets | -137.11% |
| Return on Invested Capital | 35.92% |
Valuation & Multiples
| P/E Ratio | -3.03 |
|---|---|
| PEG | 7.3 |
| Price to Sales | - |
| Price to Book Ratio | -0.06 |
| Enterprise Value to Revenue | 251.87 |
| Enterprise Value to EBIT | -2.52 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | -0.22 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Gemina Laboratories Ltd.
6 employees
CEO: Robert Crandall Greene Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface function...